A stepwise laboratory-based approach for early risk assessment of disseminated intravascular coagulation [0.03%]
一种用于早期评估弥漫性血管内凝血风险的分步实验室方法
Dajie Zhou,Jing Wang,Chengming Sun et al.
Dajie Zhou et al.
Background: Disseminated intravascular coagulation (DIC) is a life-threatening condition in which early identification is essential for timely clinical management. However, existing diagnostic approaches are often complex...
LY96-CCNT1-IFI44L core molecular features characterize VTE-associated inflammatory prothrombotic risk in elderly cancer patients [0.03%]
LY96-CCNT1-IFI44L核心分子特征表征老年癌症患者静脉血栓栓塞相关炎症促凝风险
Jie Wu,Baoji Hu,Lingyi Shao et al.
Jie Wu et al.
Background: Venous thromboembolism (VTE) is an important complication in elderly patients with cancer, yet traditional clinical scoring systems insufficiently capture its molecular heterogeneity. This study aimed to const...
Catheter-related thrombosis in oncology: A retrospective analysis of 803 long-term central venous catheters [0.03%]
803例肿瘤患者长期中心静脉导管置管相关血栓形成的回顾性分析
Margarida Pascoal,Margarida Bernardo,André Caiado et al.
Margarida Pascoal et al.
Bleeding risk in patients receiving concurrent treatment with direct oral anticoagulants and corticosteroids: A systematic review [0.03%]
直接口服抗凝剂与皮质类固醇联合治疗患者的出血风险：系统性回顾研究
Rosa Talerico,Chiara Cavallaro,Michela Iorio et al.
Rosa Talerico et al.
Background: Direct oral anticoagulants (DOACs) and corticosteroids are frequently co-prescribed in clinical practice. While both drug classes independently increase bleeding risk, the impact of their concurrent use remain...
External validation of bleeding and recurrence risk scores in patients with cancer-associated thrombosis on anticoagulant therapy [0.03%]
癌症相关血栓接受抗凝治疗患者的出血和复发风险评分的外部验证
Maria Barca-Hernando,Carmen Rosa-Linares,Victor Garcia-Garcia et al.
Maria Barca-Hernando et al.
Background: Cancer-associated thrombosis (CAT) requires balancing recurrent venous thromboembolism (VTE) risk against bleeding from anticoagulation. Most risk scores are not specific for CAT, limiting their accuracy, whil...
Letter to the editor regarding "Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: A systematic review and meta-analysis." by Nicoletto M et al [0.03%]
关于妮可莱托等撰写的“孤立性肺叶以下肺栓塞的抗凝治疗与临床观察：系统评价和Meta分析”的来信
Michele Dalla Vestra,Giuliana Autiero,Sara Angela Malerba et al.
Michele Dalla Vestra et al.
Bleeding risk prediction in elderly patients with acute PE: Progress and persistent challenges [0.03%]
老年急性肺栓塞患者的出血风险预测：进展与持续挑战
Romain Chopard
Romain Chopard
Short-term performance of bleeding risk scores in anticoagulated older patients with acute pulmonary embolism [0.03%]
口服抗凝治疗的急性肺栓塞老年患者的短期出血风险评估模型性能研究
Yuzhi Tao,Xianglong Meng,Han Tian et al.
Yuzhi Tao et al.
Background: Older patients with pulmonary embolism (PE) are at increased risk of bleeding, which is associated with adverse outcomes, making early risk assessment particularly important. This study evaluated the short-ter...
Maya D&#x;Angelo,Thomas A Mavrakanas
Maya D&#x;Angelo
Patients with end-stage renal disease face an increased thromboembolic risk but also have heightened susceptibility to bleeding. This dual risk poses a distinct challenge in managing conditions requiring anticoagulation. In this article, we...
Association between platelet to white blood cell ratio and 28-day mortality in intensive care unit patients with Sepsis: A multicentre validation study using the eICU collaborative research database [0.03%]
血小板/白细胞比值与重症监护病房中感染性休克患者28天病死率关联的多中心验证研究：基于eICU协作研究数据库的一项研究
Jixiu Fan,Jifang Liang,Shulan Wu et al.
Jixiu Fan et al.
Background: Sepsis is a leading intensive care units (ICUs) mortality cause; simple biomarkers for early risk stratification are needed, and the prognostic value of platelet to WBC ratio (PWR) in sepsis lacks large multic...